Exploring Switch II Pocket Conformation of KRAS(G12D) with Mutant-Selective Monobody Inhibitors

When expressed in cells as genetically encoded reagents, these monobodies engaged selectively with KRAS(G12D) and inhibited KRAS(G12D)-mediated signaling and tumorigenesis.